FDA clears Trigeminal nerve stimulation (TNS) as ADHD treatment

By Dr. David Rabiner | May 14, 2019

_____ Although stim­u­lant med­ica­tions are gen­er­al­ly con­sid­ered to be a safe and effec­tive treat­ment for ADHD, not all chil­dren ben­e­fit from this approach. Many par­ents are reluc­tant to begin their child on med­ica­tion and some chil­dren expe­ri­ence unac­cept­able side affects. For these rea­sons, devel­op­ing safe and effec­tive alter­na­tive treat­ments for ADHD remains a pri­or­i­ty. Trigeminal…

Read More

Next: Tools to detect and treat “chemo brain” symptoms common in around 35% of breast cancer survivors

By SharpBrains | March 23, 2015

UCLA study reveals treat­ment for women with breast can­cer suf­fer­ing cog­ni­tive dif­fi­cul­ties (Health­Canal): “UCLA researchers have devel­oped a pro­gram that could improve the day-to-day lives of women with breast can­cer by address­ing post-treat­­ment cog­ni­tive dif­fi­cul­ties, some­times known as “chemo brain,” which can affect up to 35 per­cent of women after their treatments

Read More

Why Being Young for Grade Increases Odds of ADHD Diagnosis and Stimulant Medication

By Dr. David Rabiner | June 21, 2012

ADHD is the most com­mon­ly diag­nosed neu­robe­hav­ioral dis­or­der in chil­dren and sub­stan­tial evi­dence indi­cates that bio­log­i­cal fac­tors play an impor­tant role in its devel­op­ment. For exam­ple, although the exact mech­a­nism by which genet­ic fac­tors con­vey increased risk for ADHD remains unclear, the impor­tance of genet­ic trans­mis­sion has been doc­u­ment­ed in a num­ber of pub­lished studies.…

Read More

Male clin­i­cians may be misdiag­nosing 39% of ADHD-diagnosed boys

By Alvaro Fernandez | March 23, 2012

39% We had sev­er­al read­ers high­light this strik­ing sta­tis­tic from yes­ter­day’s blog post, Is ADHD over­diag­nosed? Find­ings from a new study in Ger­many This is but anoth­er exam­ple on the grow­ing need to base behavioral/ men­tal health pre­ven­tion, diag­nos­tic and treat­ment not on symp­toms alone, but to mea­sure and incor­po­rate objec­tive mark­ers of brain func­tion, as…

Read More

Registration Opens for 2012 SharpBrains Virtual Summit: Optimizing Health through Neuroplasticity, Innovation and Data

By SharpBrains | March 15, 2012

We are pleased to con­firm a “dream team” of 30+ Speak­ers and Mod­er­a­tors to help answer the fol­low­ing ten core ques­tions on the future of brain health on June 7th and 8th. Please note that Sum­mit reg­is­tra­tion is open now, includ­ing spe­cial Very Ear­ly Bird rates until March 31st. By the year 2015, … What new tools and tech­niques will be…

Read More